Hypertrophic cardiomyopathy: The need for randomized trials
Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition characterized by variable degrees of asymmetric left ventricular (LV) hypertrophy, generally associated with mutations in sarcomere protein genes. While generally perceived as rare, HCM is the most common genetic heart disease with ove...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bloomsbury Qatar Foundation Journals
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963756/ |